Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before serovoncersion is associated with normalized immune parameters and limited viral reservoir

Lori F, Jessen H, Lieberman J, Finzi D, Rosenberg E, Tinelli C, Walker B, Siliciano RF, Lisziewicz J. Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before serovoncersion is associated with normalized immune parameters and limited viral reservoir. Journal of Infectious Diseases. 1999; 180:1827-32.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.